Historical record - last NADAC effective date: 1/1/2018
Product Information
CADUET 5 MG-80 MG TABLET is a brand product labeled by Pfizer Inc., priced at $19.1510 per EA under NDC 00069226030. Its NADAC has been published 269 times since Nov 28, 2013.
FDA first approved this application on Jan 30, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 80 mg/1; mg/1
Manufacturer
Pfizer Inc.NDC
00069226030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/1/2018
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA021540FDA Approved
1/30/2004
TE Code
AB
On Market Since
1/30/2004
Pharmacological Classes
Price Statistics
The NADAC for CADUET 5 MG-80 MG TABLET has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 122.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.1510 per EA |
|---|---|
| All-time high | $19.1510 (Jan 16, 2019) |
| All-time low | $8.6075 (Nov 28, 2013) |
| Median price | $14.6106 |
| Average price | $14.2619 |
| Largest weekly change | +9.4% (Jun 10, 2015) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+122.5%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine besylate and atorvastatin calcium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine besylate and atorvastatin calcium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CADUET 5 MG-80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CADUET 5 MG-80 MG TABLET, manufactured by Pfizer Inc., is $19.1510 per EA (NDC 00069226030), effective Jan 16, 2019.
How has the price of CADUET 5 MG-80 MG TABLET changed over time?
Over the history we have for it, the NADAC for CADUET 5 MG-80 MG TABLET has risen 122.5%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CADUET 5 MG-80 MG TABLET?
Since Nov 28, 2013, the NADAC for CADUET 5 MG-80 MG TABLET has ranged from a low of $8.6075 (Nov 28, 2013) to a high of $19.1510 (Jan 16, 2019), with a median of $14.6106 per EA.
Are there cheaper alternatives to CADUET 5 MG-80 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CADUET 5 MG-80 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CADUET 5 MG-80 MG TABLET?
CADUET 5 MG-80 MG TABLET (NDC 00069226030) is labeled by Pfizer Inc., and CMS classifies it as a brand product.